The Readout Loud
MurmurCast publishes AI-generated summaries of The Readout Loud’s Podcast episodes — 5 summarized so far, covering Pharmaceutical M&A Activity and Market Consolidation, Eli Lilly's Retatrutide Compassionate Use Program and Access Equity, FDA Leadership Changes and Policy Reversals, Gene Therapy Regulatory Decisions, Clinical Trial Process Modernization, GLP-1 Drugs and Aesthetics Market Expansion. Each summary distills the key insights, topics, and takeaways so you can decide what’s worth your time before pressing play.
407: The mysterious case of Eli Lilly's obesity drug
This biotech podcast episode discusses major pharmaceutical M&A activity, FDA regulatory changes under acting commissioner Kyle Diamantis, and a controversial compassionate use case involving Eli Lilly's obesity drug retatrutide allegedly given to a well-connected 79-year-old man (possibly President Trump, though the White House denies it).
406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises
This episode of The Read Out Loud covers two major topics: Unicure's approval pathway for its Huntington's disease gene therapy after FDA leadership changes, and a progress report on RFK Jr.'s promises as HHS Secretary, showing mixed results across vaccine policy, psychiatric medications, and nutrition guidelines.
403: Biotech exec Jeremy Levin on the industry's strategic turning point
STAT's biotech podcast covers Eli Lilly's gene-editing cholesterol drug data going viral, ASCO conference previews, and an interview with biotech executive Jeremy Levin about his new book arguing that American biotech leadership is endangered by institutional decay, short-term investing, FDA upheaval, and China's strategic rise.
402: Guarding biotech from China and big bets in longevity
This episode of The Readout Loud covers highlights from STAT's Breakthrough Summit West in San Francisco, including discussions on FDA leadership, biotech competition with Chinese companies, Eli Lilly's obesity drug data, and a detailed interview with Retro Biosciences CEO Joe Betz-Lacroix about his longevity company's clinical progress and fundraising plans.
401: Makary’s departure and Cassidy’s tenuous Senate seat
This episode of The Readout Loud covers FDA Commissioner Marty Makary's resignation and his replacement by acting commissioner Kyle Diamantis, alongside the political vulnerability of Senate Health Committee Chair Bill Cassidy ahead of a Louisiana Republican primary. The hosts and DC correspondents Lizzie Lawrence and Chelsea Ceruzzo analyze how vaping policy, abortion politics, and Trump loyalty shaped both developments.